RPRX
Royalty Pharma plc - Class A
BIOTECHNOLOGY · HEALTHCARE
Royalty Pharma Plc, headquartered in New York, is a leading entity in the biopharmaceutical royalty acquisition arena, specializing in the acquisition of royalties from established market drugs and promising development pipelines. The company's strategic focus on funding innovative therapies not onl...
$54.21
-0.11% ($0.06)
Volume
2.83M
52W High
$56.50
52W Low
$34.08
Market Cap
$22.41B
What to Watch This Quarter
Based on historical dataConsensus EPS
$1.27
Whisper EPS
$1.35
6.4% above consensus
Last Quarter
$1.30
Current Streak
6 Beats
Avg Surprise (4Q)
+10.97%
Next Earnings Report
Reports in 48 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 6, 2026
1-Day:
-1.03%
5-Day:
+1.83%
Q4 2025
Feb 11, 2026
1-Day:
+1.24%
Q3 2025
Nov 5, 2025
1-Day:
+0.89%
5-Day:
-4.65%
Q2 2025
Aug 6, 2025
1-Day:
-0.30%
5-Day:
-2.51%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $622.0M | +4.8% | 100.0% | 62.4% | $214.2M |
| Q3'25 | $609.3M | +7.9% | 100.0% | 70.1% | $288.2M |
| Q2'25 | $578.7M | +7.7% | 100.0% | 36.3% | $30.2M |
| Q1'25 | $568.2M | +0.1% | 100.0% | 94.0% | $238.3M |
| Q4'24 | $593.6M | -0.4% | 100.0% | 60.9% | $208.2M |
| Q3'24 | $564.7M | +5.3% | 100.0% | 130.2% | $544.0M |
| Q2'24 | $537.3M | -0.2% | 100.0% | 50.2% | $102.0M |
| Q1'24 | $568.0M | -17.0% | 100.0% | -13.0% | $4.8M |
Company Information
Symbol
RPRX
Company
Royalty Pharma plc - Class A
Market Cap
$22.41B
Sector
HEALTHCARE
Next Earnings
Aug 5, 2026
Also Reporting Soon
Companies reporting earnings around the same time as RPRX
HEALTHCARE Stocks
Other healthcare companies with earnings data
More in BIOTECHNOLOGY
Compare RPRX with competitors
Side-by-side earnings comparison